At the post-transcriptional level, protein degradation is primarily mediated through an ubiquitin–proteasome- or a lysosomal-dependent pathway, which can be responsible for the downregulation of ERRβ in breast cancer cells15. The gene discussed is ESRRB; the disease is breast cancer.